Literature DB >> 3693567

Immunohistochemistry in district general hospitals in England and Wales.

P A Hall1, P Domizio, G Slavin, D A Levison.   

Abstract

The findings of a survey on the use of immunohistochemistry in district general hospitals in England and Wales are reported. Immunohistochemistry is used in most district hospitals, contributes to the accuracy and objectivity of some histopathological diagnoses, and is considered to be generally useful though not without drawbacks. Its expansion is being hindered by lack of funds for reagents and staff. In a few regions attempts are being made to rationalise expenditure and coordinate development of the service. We believe that if this can be done at a regional or national level then the relatively small cost entailed will be justified by a resulting improvement in the quality of patient care.

Entities:  

Mesh:

Year:  1987        PMID: 3693567      PMCID: PMC1141229          DOI: 10.1136/jcp.40.11.1305

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Human lung tumours may coexpress different classes of intermediate filaments.

Authors:  K C Gatter; M S Dunnill; G N Van Muijen; D Y Mason
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

3.  Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques.

Authors:  K C Gatter; C Alcock; A Heryet; D Y Mason
Journal:  Lancet       Date:  1985-06-08       Impact factor: 79.321

4.  Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies.

Authors:  A K Ghosh; K C Gatter; M S Dunnill; D Y Mason
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

  4 in total
  3 in total

Review 1.  The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1998-04

2.  Use of immunochemistry in Britain: EQA forum antibody usage questionnaire.

Authors:  C A Angel; E Heyderman; I Lauder
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

3.  Comparative quality assessment in immunocytochemistry: pilot study of CD15 staining in paraffin wax embedded tissue in Hodgkin's disease.

Authors:  C A Angel; A Warford; S J Day; I Lauder
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.